A 3-year-old girl is brought to the physician by her parents for complaints of breast development and pubic hair growth for the past 6 months. She has no significant birth or medical history. The temperature is 37.0°C (98.6°F), the pulse is 88/min, and the respirations are 20/min. Physical examination shows enlarged breasts at Tanner stage 3 and pubic hair at stage 2. Height and weight are in the normal range. On GnRH stimulation testing, a luteinizing hormone (LH) response of < 5 IU/L is detected. What is the most appropriate next step in diagnosis?

Measure baseline estradiol levels and perform pelvic ultrasound

Perform leuprolide stimulation test to measure testosterone

Measure FSH levels to evaluate pituitary function

Calculate LH:FSH ratio from previous GnRH test

Repeat GnRH stimulation test to confirm LH response

A 5-year-old girl with Down syndrome presents with fatigue, pallor, and hepatosplenomegaly. Complete blood count shows WBC 45,000/μL with 80% blasts, hemoglobin 6.5 g/dL, and platelets 25,000/μL. Flow cytometry reveals blasts positive for CD19, CD10, and TdT. Cytogenetics show t(12;21) in addition to trisomy 21. Her parents ask about prognosis compared to children without Down syndrome. Synthesizing genetic and prognostic factors, what is the most accurate statement?

Down syndrome children with ALL have better outcomes than non-Down syndrome children with comparable cytogenetics

Down syndrome is associated with worse prognosis in ALL due to increased treatment-related mortality

The t(12;21) translocation negates any effect of Down syndrome on prognosis

Prognosis is identical to non-Down syndrome children when stratified by cytogenetics

Down syndrome mandates reduced-intensity chemotherapy with consequently worse outcomes

Klinefelter syndrome for USMLE Step 2 CK: High-Yield Pediatrics Lessons

Etiopathogenesis - One X Too Many

Cause: Primarily due to meiotic nondisjunction of sex chromosomes during parental gametogenesis (maternal > paternal).
Genotype: Classic form is 47,XXY. Mosaics like 46,XY/47,XXY are less common.

Karyotype of Klinefelter Syndrome (47,XXY)

Pathophysiology:
- Seminiferous tubule dysgenesis → hyalinization & fibrosis.
- This results in primary testicular failure:
  - Sertoli cell dysfunction → ↓ Inhibin B → ↑ FSH.
  - Leydig cell dysfunction → ↓ Testosterone → ↑ LH.

⭐ A Barr body (inactive X chromosome) is present in buccal smear samples.

Clinical Features - The Tall, Quiet Type

Presentation varies significantly with age, often becoming apparent after puberty.

Age Group	Clinical Manifestations
Pre-pubertal	- Often subtle: speech delay, learning disabilities (dyslexia) - Behavioral issues: shyness, anxiety - Clumsiness, poor coordination - Long limbs (arm span > height)
Post-pubertal	- Tall stature with eunuchoid proportions (↓ upper/lower segment ratio) - Gynecomastia in ~50% of cases - Small, firm testes (<2 cm, <4 mL) & micropenis - Scant facial, axillary, and pubic hair - Infertility (primary azoospermia) due to testicular fibrosis

Klinefelter Syndrome: Clinical Features

⭐ It is the most common chromosomal disorder associated with male hypogonadism and infertility.

Diagnosis - Confirming the Karyotype

Definitive Diagnosis: Karyotyping on peripheral blood lymphocytes is the gold standard, confirming the 47,XXY pattern.
Hormonal Profile: Classic Hypergonadotropic Hypogonadism.
- Lab findings: ↓ Testosterone, ↓ Inhibin B, ↑ LH, ↑ FSH.
Semen Analysis: Typically shows Azoospermia.

⭐ The hormonal profile reflects primary testicular failure. The pituitary tries to compensate by releasing high levels of gonadotropins (FSH, LH) to stimulate the non-responsive testes.

Management & Comorbidities - T-Therapy & Troubles

Mainstay: Testosterone Replacement Therapy (TRT)
- Start at puberty (12-14 years) to induce normal virilization.
- Benefits: ↑ muscle mass, ↑ bone density, improves secondary sexual characteristics, mood, and libido.
- ⚠️ Does NOT restore fertility.
Fertility Management
- Cryopreservation of sperm (if available).
- Testicular Sperm Extraction (micro-TESE) + Intracytoplasmic Sperm Injection (ICSI).
Associated Comorbidities & Risks
- Breast Cancer: ↑ 20-50x risk.
- Osteoporosis & Fractures.
- Metabolic Syndrome (Diabetes, Dyslipidemia).
- Thromboembolism (DVT, PE).
- Autoimmune Disorders (e.g., SLE).

⭐ Regular screening for comorbidities, especially annual breast exams, is a critical part of long-term management.

High-Yield Points - ⚡ Biggest Takeaways

Most common cause of hypogonadism in males; genotype 47,XXY.

Results from nondisjunction of sex chromosomes during parental gametogenesis.

Presents with tall stature, long limbs, small firm testes, and gynecomastia.

Lab findings show hypergonadotropic hypogonadism: ↓ Inhibin B, ↓ Testosterone, ↑ FSH, ↑ LH.

Diagnosis confirmed by karyotyping; a Barr body is present on buccal smear.

Associated with ↑ risk of breast cancer, metabolic syndrome, and azoospermia leading to infertility.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play